Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma.
Saved in:
| Title: | Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma. |
|---|---|
| Authors: | Brady MR; Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California., Matulionis N; Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, California., Christofk HR; Department of Biological Chemistry, University of California, Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, California., Garon EB; Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, California.; Division of Hematology and Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California., Lisberg A; Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, California.; Division of Hematology and Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California., Shackelford DB; Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, California., Momcilovic M; Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California.; Jonsson Comprehensive Cancer Center, University of California at Los Angeles, Los Angeles, California. |
| Source: | Cancer research [Cancer Res] 2026 Mar 02; Vol. 86 (5), pp. 1166-1179. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
